Closing the Lung Cancer Detection Gap for Underserved Communities
Many communities—including Black, Latino, rural, and low-income populations—face a greater burden from lung cancer and disproportionately low access to early screening. LEAP is a simple, accessible blood test designed to help detect lung cancer early—before symptoms appear and when it’s most treatable.
LEAP for the Early Detection of Lung Cancer
LEAP (Lung Enzyme Activity Profile) detects specific enzyme activity in your blood. Abnormal patterns may be linked to early-stage lung cancer—even before symptoms appear. Results are clear, fast, and help guide next steps.
The LEAP blood test detects specific enzyme patterns linked to lung cancer through a simple blood test.
An Abnormal result indicates that additional testing, like a chest CT, may be recommended by your healthcare provider.
Too Many Are Overlooked by Traditional Screening Guidelines
-
Black individuals are 15% less likely
to be diagnosed early and 16% less likely to survive 5 years.¹
-
Latino individuals are 30% more likely
to go untreated and less likely to be referred for screening.²
-
People in low-income communities
face barriers like cost, transportation, and clinic access.³
Clear Results for Clear Steps Forward
LEAP delivers straightforward results designed to support timely next steps.
A normal result provides peace of mind with continued annual testing, while an abnormal result prompts your provider to recommend follow-up care or imaging—helping you act early when it matters most.
Fast, Accessible Testing
Standard blood draw (in-clinic or on-site)
No need for advanced imaging or hospital visits
Results in just a few days
Mobile phlebotomy options available
Partnering with healthcare organizations and philanthropic funders
Why Consider LEAP?
LEAP supports early detection efforts by identifying molecular signals in your blood—potentially before lung cancer would show up on a scan.
LEAP is clinically validated
with 99.8% negative predictive value
-
Simple
Requires only a standard blood draw
-
Safe
No radiation, no imaging, no prep
-
Fast
Receive results in just a few days
-
Proactive
May trigger earlier follow-up care
-
Trusted
Backed by clinical research and performed in a CLIA-certified lab
How to Get the LEAP Test
-
Talk to your healthcare provider
Your doctor can help determine if LEAP is appropriate for you. Contact Ease Healthcare for a listing of providers.
-
Complete your blood draw
Testing is done either in your provider’s office or through a participating Ease Healthcare partner.
-
Review your results
You’ll receive your results within a few days, and your doctor will explain what they mean and recommend next steps if needed.
More Information About LEAP
Is the LEAP test covered by insurance?
Most health insurance plans do not currently cover the cost of the LEAP test. However, you may be able to use pre-tax dollars from a Flexible Spending Account (FSA) or Health Savings Account (HSA). Check with your plan administrator or insurance provider to confirm eligibility.
Is LEAP FDA-approved?
No. LEAP is a laboratory-developed test (LDT) that has not been cleared or approved by the FDA. It is performed by a CLIA-certified and CAP-accredited lab authorized to conduct high-complexity clinical testing.
Can LEAP give false results?
Yes. Like all medical tests, LEAP may produce false-positive or false-negative results.
A false-positive result means the test indicates a possible issue when no cancer is present.
A false-negative result means the test may miss the presence of cancer.
Test results should always be interpreted by a healthcare provider in the context of your medical history and current symptoms.
¹Radiology. Kathuria H, et al., Racial and Ethnic Disparities in Lung Cancer Screening: A Narrative Review. 2021.
²American Lung Association. State of Lung Cancer 2023 Report.
³BMC Public Health. Investigating socioeconomic disparities in lung cancer diagnosis and outcomes. 2024.
LEAP RESOURCES
RELATED NEWS & UPDATES